Calvert Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-114,881
Closed -$16.8M 39
2016
Q4
$16.8M Sell
114,881
-14,321
-11% -$2.16M 0.63% 33
2016
Q3
$21.6M Sell
129,202
-8,435
-6% -$1.43M 0.79% 19
2016
Q2
$20.9M Sell
137,637
-60,193
-30% -$9.36M 0.84% 17
2016
Q1
$29.7M Buy
197,830
+6,299
+3% +$936K 1.31% 13
2015
Q4
$31.1M Sell
191,531
-40,042
-17% -$6.29M 1.42% 11
2015
Q3
$32M Buy
231,573
+7,212
+3% +$1.14M 1.6% 12
2015
Q2
$34.4M Buy
224,361
+124,654
+125% +$20M 1.52% 15
2015
Q1
$15.9M Sell
99,707
-18,088
-15% -$2.85M 1.03% 18
2014
Q4
$18.8M Buy
117,795
+38,457
+48% +$5.99M 1.28% 11
2014
Q3
$11.1M Sell
79,338
-131,078
-62% -$17.1M 0.83% 26
2014
Q2
$24.9M Buy
210,416
+28,086
+15% +$3.25M 1.67% 13
2014
Q1
$22.5M Buy
182,330
+194
+0.1% +$23.5K 1.59% 12
2013
Q4
$20.8M Buy
182,136
+131,778
+262% +$15M 1.52% 12
2013
Q3
$5.64M Sell
50,358
-220
-0.4% -$23.9K 0.7% 52
2013
Q2
$4.99M Buy
+50,578
New +$5.25M 0.68% 53

Other funds holding AMGN

Calvert Investment Management's AMGN Position: Q1 2017 in Review

Calvert Investment Management sold out of Amgen (AMGN) in Q1 2017, closing a stake of 114,881 shares — an estimated $16.8M sold.

Calvert Investment Management first reported a position in AMGN in Q2 2013 and held it in 15 quarters. The position peaked at $34.4M in Q2 2015. 1,600 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.

  • Calvert Investment Management reported no remaining Amgen position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 114,881 Amgen shares in Q1 2017, an estimated $16.8M.
  • Calvert Investment Management first reported a position in Amgen in Q2 2013 and held it in 15 quarters.
  • Calvert Investment Management's Amgen position peaked at $34.4M in Q2 2015.
  • 1,600 funds tracked by Wall St. Rank held Amgen as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.